Smith Beth Ann 4

What Happened

• Beth Ann Smith, VP, Controller & Treasurer of MacroGenics (MGNX), received two restricted stock unit (RSU) awards on 2026-02-12 totaling 109,375 RSUs (15,625 + 93,750).
• On 2026-02-15 the filing shows conversion/exercise activity of 1,095 derivative units into common shares. To cover tax withholding, 423 shares were surrendered (code F) at a reported share value of $1.71, producing a withholding amount of about $723.
• The Form 4 also lists a related derivative “disposed” entry for 1,095 shares at $0, which appears to reflect settlement mechanics of the conversion (reported as code M for exercise/conversion).

Key Details

• Transaction dates: RSU grants on 2026-02-12; conversion/exercise and tax withholding on 2026-02-15. Filing date: 2026-02-17.
• Grant amounts: 15,625 RSUs and 93,750 RSUs (total 109,375 RSUs) reported as awards (code A).
• Conversion/exercise: 1,095 derivative units converted into shares (code M). Tax withholding: 423 shares withheld at $1.71/share for ~$723 (code F).
• Shares owned after transaction: not specified in the filing.
• Footnotes: prior RSU grant details and vesting schedules are included (e.g., a Feb 15, 2023 grant vesting in annual installments; RSUs convert one-for-one to common stock; staged vesting percentages noted).
• Filing timeliness: Form filed 2026-02-17 covering Feb 12/15 activity; the filing does not indicate a late-report designation in the text of this summary.

Context

• These transactions are largely awards and a conversion/settlement plus tax-withholding — typical reporting when RSUs vest or derivatives convert. The 423-share disposition was to satisfy tax obligations (not an open‑market sale for cash).
• RSU grants are awards (not purchases) and do not by themselves signal a directional market bet; tax withholding and settlement entries are routine administrative steps following vesting or conversion.